Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

329 ARTÍCULOS , VIENDO DEL 106 AL 120

[Active management of patients with Alzheimer disease]

Derouesné C.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Sep;11(3):273-4. doi: 10.1684/pnv.2013.0420.

Animal models of Alzheimer's disease and drug development

Laurijssens B, Aujard F, Rahman A.

Drug Discov Today Technol. 2013 Sep;10(3):e319-27. doi: 10.1016/j.ddtec.2012.04.001.

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity

Lublin AL, Link CD.

Drug Discov Today Technol. 2013 Spring;10(1):e115-e119. doi: 10.1016/j.ddtec.2012.02.002.

Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease

Melancon BJ, Tarr JC, Panarese JD, Wood MR, Lindsley CW.

Drug Discov Today. 2013 Dec;18(23-24):1185-99. doi: 10.1016/j.drudis.2013.09.005. Epub 2013 Sep 17.

Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?

Li Y, Liu Y, Wang Z, Jiang Y.

Expert Opin Biol Ther. 2013 Nov;13(11):1515-22. doi: 10.1517/14712598.2013.838555. Epub 2013 Sep 22.

Discovering new treatments for Alzheimer's disease by repurposing approved medications

Appleby BS, Cummings JL.

Curr Top Med Chem. 2013;13(18):2306-27. doi: 10.2174/15680266113136660162.

[Donepezil in Alzheimer's disease and vascular dementia]

Damulin IV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7):71-5.

Implication of the nutritional and nonnutritional factors in the context of preservation of cognitive performance in patients with dementia/depression and Alzheimer disease

Aliev G, Ashraf GM, Kaminsky YG, Sheikh IA, Sudakov SK, Yakhno NN, Benberin VV, Bachurin SO.

Am J Alzheimers Dis Other Demen. 2013 Nov;28(7):660-70. doi: 10.1177/1533317513504614. Epub 2013 Oct 1.

Association between hospice care and psychological outcomes in Alzheimer's spousal caregivers

Irwin SA, Mausbach BT, Koo D, Fairman N, Roepke-Buehler SK, Chattillion EA, Dimsdale JE, Patterson TL, Ancoli-Israel S, Mills PJ, von Känel R, Ziegler MG, Grant I.

J Palliat Med. 2013 Nov;16(11):1450-4. doi: 10.1089/jpm.2013.0130. Epub 2013 Oct 5.

Antidepressants for neuro-regeneration: from depression to Alzheimer's disease

Kim HJ, Kim W, Kong SY.

Arch Pharm Res. 2013 Nov;36(11):1279-90. doi: 10.1007/s12272-013-0238-8. Epub 2013 Oct 16.

Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study

Miyoshi I, Fujimoto Y, Yamada M, Abe S, Zhao Q, Cronenberger C, Togo K, Ishibashi T, Bednar MM, Kupiec JW, Binneman B.

Int J Clin Pharmacol Ther. 2013 Dec;51(12):911-23. doi: 10.5414/CP201816.

Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design

Hoffmann K, Frederiksen KS, Sobol NA, Beyer N, Vogel A, Simonsen AH, Johannsen P, Lolk A, Terkelsen O, Cotman CW, Hasselbalch SG, Waldemar G.

Neuroepidemiology. 2013;41(3-4):198-207. doi: 10.1159/000354632. Epub 2013 Oct 15.

Current and emerging therapies for Alzheimer's disease

Nygaard HB.

Clin Ther. 2013 Oct;35(10):1480-9. doi: 10.1016/j.clinthera.2013.09.009.

Immunotherapy for Alzheimer's disease: hoops and hurdles

Lemere CA.

Mol Neurodegener. 2013 Oct 22;8:36. doi: 10.1186/1750-1326-8-36.

Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection

Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D.

Eur J Med Chem. 2013;70:165-88. doi: 10.1016/j.ejmech.2013.09.050. Epub 2013 Oct 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias